ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,828.40
      -0.09%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.635
      -0.84%
      Bitcoin
      62,804.16
      -3.16%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. International Stem Cell Corporation (QB) (ISCO)

      7. International Stem Cell Corporation (QB) (ISCO) News

      ISCO

      International Stem Cell (QB) (ISCO)

      International Stem Cell Corporation (QB)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:ISCO
      DateTimeSourceHeadlineSymbolCompany
      04/29/20198:30AMInvestorsHub NewsWireInternational Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clinical TrialUSOTC:ISCOInternational Stem Cell Corporation (QB)
      04/23/20194:33PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
      04/22/20192:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      04/16/20198:30AMInvestorsHub NewsWireInternational Stem Cell Corporation Announces 2018 Fourth Quarter and Year-End ResultsUSOTC:ISCOInternational Stem Cell Corporation (QB)
      04/15/20196:13AMEdgar (US Regulatory)Annual Report (10-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
      04/01/20194:32PMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
      03/07/20196:05AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:ISCOInternational Stem Cell Corporation (QB)
      03/04/20194:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      03/04/20194:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      03/04/20194:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      02/13/20198:30AMInvestorsHub NewsWireInternational Stem Cell Corporation Publishes Successful Results in Traumatic Brain InjuryUSOTC:ISCOInternational Stem Cell Corporation (QB)
      01/23/20194:27PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
      01/22/20196:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      01/15/20198:30AMInvestorsHub NewsWireInternational Stem Cell Corporation Granted Key US Patent Protecting Anti-Aging BusinessUSOTC:ISCOInternational Stem Cell Corporation (QB)
      12/06/20188:04AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      12/06/20188:01AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      12/05/20188:30AMInvestorsHub NewsWireInternational Stem Cell Corporation is Valued at $6.16 per Share by Edison Investment ResearchUSOTC:ISCOInternational Stem Cell Corporation (QB)
      11/15/20188:30AMInvestorsHub NewsWireInternational Stem Cell Corporation Announces Strong Financial Results for the Three and Nine-Months ended September 30, 2018USOTC:ISCOInternational Stem Cell Corporation (QB)
      11/15/20186:07AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
      11/14/20185:01PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:ISCOInternational Stem Cell Corporation (QB)
      11/05/20188:30AMInvestorsHub NewsWireInternational Stem Cell Corporation Announces Positive Top-Line Preliminary Results from Parkinson's Disease Clinical TrialUSOTC:ISCOInternational Stem Cell Corporation (QB)
      10/30/20188:30AMInvestorsHub NewsWireInternational Stem Cell Corporation to Present Clinical Data at the Society for Neuroscience Annual MeetingUSOTC:ISCOInternational Stem Cell Corporation (QB)
      10/08/20188:30AMInvestorsHub NewsWireInternational Stem Cell Corporation Doses Tenth Patient in Parkinson's Disease Clinical TrialUSOTC:ISCOInternational Stem Cell Corporation (QB)
      10/03/20184:47PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ISCOInternational Stem Cell Corporation (QB)
      10/03/20184:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
      10/02/20188:00AMInvestorsHub NewsWireInternational Stem Cell Corporation Raised Funds Through a Private Placement at Premium to MarketUSOTC:ISCOInternational Stem Cell Corporation (QB)
      09/27/20183:05PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:ISCOInternational Stem Cell Corporation (QB)
      09/27/20183:04PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:ISCOInternational Stem Cell Corporation (QB)
      09/27/20183:03PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:ISCOInternational Stem Cell Corporation (QB)
      08/22/20186:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:ISCOInternational Stem Cell Corporation (QB)
       Showing the most relevant articles for your search:USOTC:ISCO